Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Elizabeth Middleton National
Primary Care Research and Development Centre, University of Manchester,
Manchester M13 9PL Correspondence to: D Baker d.j.baker@salford.ac.uk
| The first 150 words of the full text of this article appear below. |
Since the late 1990s, the possible adverse effects of
the combined measles, mumps, and rubella (MMR) vaccine have caused
intense public debate. After the vaccine was introduced in 1988, coverage was high, increasing from 80% in 1989 to 92% in 1997. After
1997 coverage began to decline,1 and by 2001 had fallen by
4.1%, which gave some cause for concern.2 We examined the
extent to which these trends reflect different patterns of uptake in affluent and deprived areas and changes in the equitable coverage of
immunisation for MMR.
| |
Participants, methods, and results |
|---|
We selected 60 health authorities in England (defined by 1999 boundaries). The boundaries of these authorities remained stable over a
decade. We calculated the Townsend material deprivation index for each
area and used these scores to categorise authorities in to three groups
of 20 authorities3: deprived (1.27 to 10.59), neither
deprived nor affluent (
2.41 to 1.13), or affluent (
4.51 to
2.79). For each year from 1991 to 2001, we
Read all Rapid Responses